E-LIB Suche - Ergebnisse für: Honig, Peter K.

1

Real‐World Evidence and the Regulation of Medicines:

Honig, Peter K.
Clinical Pharmacology & Therapeutics. 109 (2021) 5 - p. 1169-1172 , 2021

2

A Useful and Sustainable Role for N‐of‐1 Trials in the Heal..:

Selker, Harry P. ; Cohen, Theodora ; D'Agostino, Ralph B....
Clinical Pharmacology & Therapeutics. 112 (2021) 2 - p. 224-232 , 2021

Link: https://doi.org/10.1002/..

3

The "Coming of Age" of Real‐World Evidence in Drug Developm..:

Honig, Peter K
Clinical Pharmacology & Therapeutics. 111 (2021) 1 - p. 11-14 , 2021

Link: https://doi.org/10.1002/..

4

Overcoming Regulatory Aversion to Novel Methods of Evidence..:

Baumfeld Andre, Elodie ; Honig, Peter K.
Clinical Pharmacology & Therapeutics. 107 (2019) 5 - p. 1057-1058 , 2019

Link: https://doi.org/10.1002/..

5

Efficacy and Effectiveness Too Trials: Clinical Trial Desig..:

Selker, Harry P. ; Eichler, Hans‐Georg ; Stockbridge, Norman L....
Clinical Pharmacology & Therapeutics. 105 (2019) 4 - p. 857-866 , 2019

Link: https://doi.org/10.1002/..

6

The Fourth Hurdle: Commentary on "Weighing Of Evidence By H..:

Honig, Peter K
Clinical Pharmacology & Therapeutics. 105 (2018) 3 - p. 561-562 , 2018

Link: https://doi.org/10.1002/..

7

EDITORIAL BOARD:

, In: Pharmacology and Therapeutics,

Abernethy, Darrell R. ; Atkinson Jr., Arthur J. ; Benowitz, Neal L.... - p. ii , 2009

Link: https://doi.org/10.1016/..

8

EDITORIAL BOARD:

, In: Pharmacology and Therapeutics,

Abernethy, Darrell R. ; Atkinson Jr., Arthur J. ; Benowitz, Neal L.... - p. ii , 2009

Link: https://doi.org/10.1016/..

9

Improving the quality of adverse drug reaction reporting by..:

Rosebraugh, Curtis J. ; Tsong, Yi ; Zhou, Feng...
Pharmacoepidemiology and Drug Safety. 12 (2003) 2 - p. 97-101 , 2003

Link: https://doi.org/10.1002/..

10

Centers for Education and Research on Therapeutics report: ..:

Rosebraugh, Curtis J. ; Honig, Peter K. ; Yasuda, Sally Usdin..
Clinical Pharmacology & Therapeutics. 71 (2002) 1 - p. 4-10 , 2002

Link: https://doi.org/10.1067/..

11

Clinical consequences of 'failed' bioequivalence studies:

Lesko, Lawrence J. ; Bashaw, Dennis ; Conner, Dale P..
European Journal of Drug Metabolism and Pharmacokinetics. 25 (2000) 1 - p. 69-69 , 2000

Link: https://doi.org/10.1007/..

12

Clinical Significance of Pharmacokinetic Drug Interactions ..:

Honig, Peter K. ; Gillespie, Bradley K.
Clinical Pharmacokinetics. 35 (1998) 3 - p. 167-171 , 1998

Link: https://doi.org/10.2165/..

13

Drug Metabolism in Drug Development: A DIA Tutorial for Reg..:

Honig, Peter K. ; Cantilena, Louis R. ; Santone, Kenneth S.
Drug Information Journal. 32 (1998) 1 - p. 163-167 , 1998

Link: https://doi.org/10.1177/..

14

Temporal decline in filling prescriptions for terfenadine c..:

Burkhart, Greg A. ; Sevka, Michael J. ; Temple, Robert.
Clinical Pharmacology & Therapeutics. 61 (1997) 1 - p. 93-96 , 1997

Link: https://doi.org/10.1016/..

15

Grapefruit Juice Alters the Systemic Bioavailability and Ca..:

Honig, Peter K. ; Wortham, Dale C. ; Lazarev, Alexander.
The Journal of Clinical Pharmacology. 36 (1996) 4 - p. 345-351 , 1996

Link: https://doi.org/10.1002/..